Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy

被引:254
|
作者
Anolik, Jennifer H. [1 ]
Barnard, Jennifer [1 ]
Owen, Teresa [1 ]
Zheng, Bo [1 ]
Kemshetti, Sunil [1 ]
Looney, R. John [1 ]
Sanz, Inaki [1 ]
机构
[1] Univ Rochester, Sch Med, Rochester, NY 14642 USA
来源
ARTHRITIS AND RHEUMATISM | 2007年 / 56卷 / 09期
关键词
T-CELLS; IN-VIVO; RHEUMATOID-ARTHRITIS; CYTOKINE SECRETION; SOMATIC MUTATION; DISEASE-ACTIVITY; RITUXIMAB; RECONSTITUTION; POPULATION; TRIAL;
D O I
10.1002/art.22810
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Recent data suggest that the reconsti- tuting peripheral B cell compartment after B cell depletion therapy may be functionally immature, with a preponderance of transitional B cells and a paucity of memory B cells. This study was undertaken to determine the magnitude, duration, and cause of these defects in rituximab-treated systemic lupus erythematosus (SLE) patients. Methods. Fifteen patients with SLE previously treated with rituximab as part of a phase I/II dose-escalation study were evaluated during a long-term followup (mean followup period 41 months). B cells from peripheral blood and tonsils were assessed using multicolor flow cytometry, and their developmental pathway was classified based on the expression of defined surface markers. Results. Reconstitution of peripheral blood CD27+ memory B cells was delayed for several years after B cell depletion therapy in a subset of patients with prolonged clinical responses and autoantibody normalization. This delay correlated with the degree of expansion of B cells of a transitional phenotype during the B cell reconstitution phase (P = 0.005) and the absence of baseline autoantibodies directed against extractable nuclear antigens (RNP, Sm, Ro antigen, La antigen). Despite the paucity of peripheral blood memory cells and the prolonged expansion of functionally immature transitional B cells, tonsil biopsy tissues revealed active germinal center (GC) reactions, but with decreased Fc receptor homolog 4-positive memory B cells. Conclusion. These results suggest heterogeneity in the B cell depletion and reconstitution process that impacts clinical and immunologic outcomes in SLE. The presence of GC reactions, but with altered memory B cell subpopulations in tonsils, suggests that peripheral blood memory cell reconstitution lags behind a slow secondary lymphoid tissue recovery, with important implications for immunologic competence and tolerance.
引用
收藏
页码:3044 / 3056
页数:13
相关论文
共 50 条
  • [41] Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus
    Anolik, JH
    Barnard, J
    Cappione, A
    Pugh-Bernard, AE
    Felgar, RE
    Looney, RJ
    Sanz, I
    ARTHRITIS AND RHEUMATISM, 2004, 50 (11): : 3580 - 3590
  • [42] Does B cell depletion have a role to play in the treatment of systemic lupus erythematosus?
    Gorman, C
    Leandro, M
    Isenberg, D
    LUPUS, 2004, 13 (05) : 312 - 316
  • [43] B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus
    Marks, SD
    Patey, S
    Brogan, PA
    Hasson, N
    Pilkington, C
    Woo, P
    Tullus, K
    ARTHRITIS AND RHEUMATISM, 2005, 52 (10): : 3168 - 3174
  • [44] Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus
    Reddy, Venkat
    Cambridge, Geraldine
    Isenberg, David A.
    Glennie, Martin J.
    Cragg, Mark S.
    Leandro, Maria
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (08) : 2046 - 2055
  • [45] Ofatumumab for B cell depletion in patients with systemic lupus erythematosus who are allergic to rituximab
    Masoud, Sherry
    McAdoo, Stephen P.
    Bedi, Rachna
    Cairns, Thomas D.
    Lightstone, Liz
    RHEUMATOLOGY, 2018, 57 (07) : 1156 - 1161
  • [46] BELIMUMAB DISRUPTS MEMORY B CELL TRAFFICKING IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Arends, Eline J.
    Zlei, Mihaela
    Tipton, Christopher M.
    Osmani, Zgjim
    de Bie, Fenna
    Kamerling, Sylvia W. A.
    Rabelink, Ton
    Sanz, Ignacio
    van Dongen, Jacques J. M.
    van Kooten, Cees
    Teng, Yeo K. O.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I170 - I170
  • [47] Prolonged B-cell depletion following rituximab therapy in systemic lupus erythematosus: a report of two cases
    Lu, T. Y-T
    Jonsdottir, T.
    van Vollenhoven, R. F.
    Isenberg, D. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (10) : 1493 - 1494
  • [48] Targeted B-cell depletion therapy in childhood-onset systemic lupus erythematosus: Progress to date
    Marks S.D.
    Tullus K.
    Pediatric Drugs, 2007, 9 (6) : 371 - 378
  • [49] Severe gastrointestinal involvement in systemic lupus erythematosus treated with rituximab and cyclophosphamide (B-cell depletion therapy)
    Waite, L.
    Morrison, E.
    LUPUS, 2007, 16 (10) : 841 - 842
  • [50] Long term follow up of patients with systemic lupus erythematosus (SLE) after B cell depletion.
    Ng, Kristine P.
    Leandro, Maria J.
    Edwards, Jonathan C.
    Cambridge, Geraldine
    Isenberg, David A.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S258 - S258